Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

    Limited submission

    This grant supports NCI-designated Cancer Centers in advancing cancer research, collaboration, and resource sharing across basic, clinical, and population-based science.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

    This grant funds NCI-Designated Cancer Centers to support and integrate diverse cancer research, foster collaboration, develop shared resources, and advance cancer prevention, diagnosis, and treatment.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)

    This grant supports centers at institutions with strong existing research in NIDDK-related diseases, funding shared resources, collaboration, mentoring, and pilot programs to advance research in areas like diabetes, obesity, and liver diseases.

    HHS-NIH11Forecasted Jun 1, 2027Forecasted

    Single Source Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)

    This grant will fund a single Coordinating Center to manage research resources, data, and collaboration for the Small Cell Lung Cancer Consortium over five years.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    HHS-NIH11Due Nov 5, 2026· 5d

    Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional)

    NIH's limited competition supports partnerships between resource-limited institutions and designated cancer centers to strengthen cancer research, infrastructure, training, and outreach.

    HHS-NIH11Due Jan 25, 2027$9,000,000Limited submission